The Epoch Times
The Epoch Times
Focus

virus rebound

Long COVID
Long COVID
|
A.C. Dahnke

Paxlovid Doesn’t Reduce Risk of Long COVID, Potentially Linked to Rebound Symptoms: Study

Researchers found little difference in outcomes between Paxlovid users and nonusers. They also found 1 in 5 users experienced rebound symptoms.
Jan 05, 2024
|
A.C. Dahnke
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Paxlovid Doesn’t Reduce Risk of Long COVID, Potentially Linked to Rebound Symptoms: Study
Jan 05
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Health News
Health News
|
Xiaoxu Sean Lin, Jacky Guan

All Vaccines Perform Worse Than Natural Immunity Against COVID: Systematic Review and Meta-Analysis

Mar 16, 2023
|
Xiaoxu Sean Lin
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
All Vaccines Perform Worse Than Natural Immunity Against COVID: Systematic Review and Meta-Analysis
Mar 16
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
home-iconepochtv-iconhealth-iconbright-iconepochfun-icon
The Epoch Times
Copyright © 2000 - 2025 The Epoch Times Association Inc. All Rights Reserved.